Arterial foci of F-18 fluorodeoxyglucose are associated with an enhanced risk of subsequent ischemic stroke in cancer patients: A case-control pilot study

Clinical Nuclear Medicine

Volumn 36, Issue 2, 2011, Pages 85-90

  Grandpierre, Solène ^a,b   Desandes, Emmanuel ^b,c   Meneroux, Benoit ^a,b   Djaballah, Wassila ^a,b,d   Mandry, Damien ^a,b,d   Netter, Fanny ^a,b   Wahl, Denis ^a,b,e   Fay, Renaud ^e   Karcher, Gilles ^a,b   Marie, Pierre Yves ^a,b,e  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c CENTRE ALEXIS VAUTRIN   (France)

^d UNIVERSITÉ DE LORRAINE   (France)

^e INSERM   (France)

Author keywords

F 18 FDG; hybrid PET CT imaging; stroke; unstable atherosclerosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; AORTA ARCH; ARTICLE; BRAIN ISCHEMIA; CANCER LOCALIZATION; CANCER PATIENT; CAROTID ARTERY BIFURCATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; RISK ASSESSMENT;

AGED; ARTERIES; BIOLOGICAL TRANSPORT; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; RISK; STROKE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79551574936     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318203bb42     Document Type: Article

References (33)

1. Grisold W, Oberndorfer S, Struhal W. Stroke and cancer: a review. Acta Neurol Scand. 2009;119:1-16.
2. Yusuf SW, Peter Razeghi P, Yeh ET. The diagnosis and management of cardiovascular disease in cancer patients. Curr Probl Cardiol. 2008;33:163-196.
3. Chen W, Bural GG, Torigian DA, et al. Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging. 2009;36:144-151.
4. 18F] fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur J Nucl Med Mol Imaging. 2003;30:267-273.
5. Rudd JH, Warburton EA, Fryer TD, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708-2711.
6. Ogawa M, Ishino S, Mukai T, et al. (18)F-FDG accumulation in atheroscle-rotic plaques: immunohistochemical and PET imaging study. J Nucl Med. 2004;45:1245-1250.
7. Tawakol A, Migrino RQ, Hoffmann U, et al. Noninvasive in vivo measure-ment of vascular inflammation with F-18 fluorodeoxyglucose positron emis-sion tomography. J Nucl Cardiol. 2005;12:294-301.
8. Zhang Z, Machac J, Helft G, et al. Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopatholog-ical correlation BMC Nucl Med. 2006;6:3.
9. Tawakol A, Migrino RQ, Bashian GG, et al. In Vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque in flammation inpatients. J Am CollCardiol. 2006;48:1818-1824.
10. Defawe OD, Hustinx R, Defraigne JO, et al. Distribution ofF-18 fluorode-oxyglucose (F-18 FDG) in abdominal aortic aneurysm: high accumulation in macrophages seen on PET imaging and immunohistology. Clin Nucl Med. 2005;30:340-341.
11. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
12. Bural GG, Torigian DA, Chamroonrat W, et al. FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging. 2008;35:562-569.
13. 18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol. 2007;49:1533-1539.
14. Joly L, Djaballah W, Koehl G, et al. Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification. Eur J Nucl Med Mol Imaging. 2009;36: 979-985
15. Arauz A, Hoyos L, Zenteno M, et al. Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron emission tomography. Pilot study. Clin Neurol Neurosurg. 2007;109:409-412.
16. Ben-Haim S, Kupzov E, Tamir A, et al. Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies. J Nucl Cardiol. 2006;13:791-800.
17. Kronzon I, Tunick PA. Aortic atherosclerotic disease and stroke. Circulation. 2006;114:63-75.
18. Golledge J, Siew DA. Identifying the carotid "high risk" plaque: is it still a riddle wrapped up in an enigma? Eur J Vasc Endovasc Surg. 2008;35:2-8.
19. McCollough CH, Ulzheimer S, Halliburton SS, et al. Coronary artery cal-cium: a multiinstitutional multimanufacturer international standard for quan-tification at cardiac CT. Radiology. 2007;243:527-538.
20. Rudd JH, Myers KS, Bansilal S, et al. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol. 2007;50:892-896.
21. Rudd JH, Myers KS, Bansilal S, et al. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quan-tification methods, and recommendations. J Nucl Med. 2008;49:871-878.
22. Davies JR, Rudd JH, Fryer TD, et al. Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke. 2005;36:2642-2647.
23. Demopoulos LA, TunickPA, BernsteinNE, etal. Protrudingatheromas of the aortic arch and neurologic events in patients with carotid artery disease. Am Heart J. 1995;129:40-44.
24. Meissner I, Khandheria BK, Sheps SG, et al. Atherosclerosis of the aorta: risk factor, risk marker, or innocent bystander? A prospective population-based trans-esophageal echocardiography study. J Am Coll Cardiol. 2004;44:1018-1024
25. Tatsumi M, Cohade C, Nakamoto Y, et al. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology. 2003;229:831-837.
26. Paulmier B, Duet M, Khayat R, et al. Arterial wall uptake of fluorodeoxy-glucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J Nucl Cardiol. 2008;15:209-217.
27. Tahara N, Kai H, Nakaura H, et al. The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose positron emission tomog-raphy. Eur Heart J. 2007;28:2243-2248.
28. Tahara N, Kai H, Ishibashi M, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006;48:1825-1831.
29. Ogawa M, Magata Y, Kato T, et al. Application of F-FDG PET for moni-toring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques. J Nucl Med. 2006;47:1845-1850.
30. Selim N. Perioperative stroke. NEngl JMed. 2007;356:706-713.
31. Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors of ischemic strokes. Stroke. 2003;34:2518-2532.
32. Di Napoli M, Papa F. Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients. Stroke. 2002;33:1763-1771.
33. Meirelles GS, Gonen M, Strauss HW. 18F-FDG uptake and calcifications in the thoracic aorta on positron emission tomography/computed tomography examinations: frequency and stability on serial scans. J Thorac Imaging. In press.